Prοf. Emeritus Stavros J Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine of Aristotelian University of Thessaloniki, Postgraduate training (a) in Neurology in Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Ph...
Prοf. Emeritus Stavros J Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine of Aristotelian University of Thessaloniki, Postgraduate training (a) in Neurology in Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia, USA (c) in Neurootology and Neuropathology of Auditory pathway in Harvard University, (d).Neuropathology and Experimental Neurology, University of Pennsylvania, (e) Neuroimmunology, Yale University, New Haven. Research on Blood Brain Barrier in dementias, Blood Brain Barrier in Demyelinating diseases, Mitochondria in Alzheimer’s disease, Synaptogenesis in vivo and in vitro, Neuronal apoptosis in dementias and demyelinating diseases, Dendritic pathology in dementias, Pathology of Golgi apparatus in dementias. Special interests: Neuroethics, Neurolinguistics, Philosophy of Neurosciences, Application of mathematics in Neurosciences, Neurology and the Art. Member of 40 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for support of health and medical education in Africa.He was visiting professor in Tufts University, Democretian University, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 textbooks on Neurology, Neuropathology, Neuropsychology and of 678 papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neurotics.
Distinctions 12 Gold medals. Title Archon Actuarius of the Ecoumenical Patriarchate of Constantinople’s.
Head of the 1st Department of Neurology, Aristotelian University for 20 years (1992-2011).Emeritus Professor of Neurology, Aristotelian University, Thessaloniki, Greece. Director of Research Institute for Alzheimer’s disease, Iraklion, Langada.
Recearch on Electron microscopy concerning; Blood Brain Barrier in dementias; Blood brain barrier in demyelinated diseases; Mitochondria in Alzheimer’s disease; Golgi apparatus in Alzheimer’s disease; Synaptogenesis in vivo and in vitro; Neuronal apoptosis in dementias and demyelinating diseases; Acoustic cortex in dementias; The vascular factor in neurodegenerative conditions.
Dr. Juan F Martinez canca, MD, MRCS, qualified as a Doctor in Medicine and Surgery at the University of Málaga (Spain) in 1994 and trained as Brain and Spinal Surgeon in London (UK) since 1996 where he gained a National Training Number (NTN) at the South Thames Deanery. He continued to work for the United Kingdom National Health Service until 2010. He currently works in Spain and has established private practice at several locations in the Middle East.
In addition to general neurosurgical practice (neuro-traumatology, neuro intensive care medicine, spinal neurosurgery, neurovascular pathology and peripheral nerve pathology), his clinical and surgical experience is constantly updated through numerous international courses and workshops in operative neurosurgery. Consultant Neurosurgeon at NeuroKonsilia and Magna Clinic Medical Research Institute, he is developing along with a team of pioneer scientists an innovative research line on Autologous Stem Cell Therapy (ASCT) applied to Neurosciences. He is also Senior Advisor in Neuro-Oncological Hyperthermia and Plasma Generator therapy.
Partner at Neurobridge Consulting, in parallel with his professional activities, he is Consultant in Holistic Medicine and co-founder of the International Holistic Therapy Center formerly known as The Center for Brain Respiration based in London and Marbella, entirely funded and supported by charity. This initiative is part of the extended network at The Breathing Group Corporation.
Brain and spinal tumours, both adult and paediatric, as well as spinal surgery with particular emphasis in minimally invasive procedures.
Dr. Arun Oommen is the consultant neurosurgeon at Lakeshore Hospital and Research Centre, Kochi, India. After his super specialty training and fellowship training in Neuro endoscopy, he has worked in various super specialty centers. He is well trained to handle major neurosurgical cases, including Neurotrauma, degenerative spine disease, Steriotaxic Neuro surgery and Neuro oncology. He is well versed in Neuro navigation and spine instrumentation. He is actively involved in various teaching programs, active participant in various conferences, and regular writer for various medical magazines.
Dr. Arun Oommen is the consultant neurosurgeon at Lakeshore Hospital and Research Centre, Kochi, India. After his super specialty training and fellowship training in Neuro endoscopy, he has worked in various super specialty centers. He is well trained to handle major neurosurgical cases, including Neurotrauma, degenerative spine disease, Steriotaxic Neuro surgery and Neuro oncology. He is well versed in Neuro navigation and spine instrumentation. He is actively involved in various teaching programs, active participant in various conferences, and regular writer for various medical magazines.
Neuro Trauma and Neuro critical care; Neuro navigation; Steriotaxic neurosurgery; Neuro endoscopy; Neuro rehabilitary care in head injury survivors; Spine instrumentation.
Dr. Waseem Aziz is a lecturer of neurosurgery at Alexandria University. Dr. Aziz is a board member of the Egyptian Society of Neurological Surgery (ESNS), a board Member of the Egyptian Cerebrovascular Group of ESNS, board member of the Pan Arab Neurosurgical Society, member of the Congress of Neurological Surgeons (CNS), member of the American Association of Neurological Surgeons.
He was graduated from Alexandria University, Alexandria, Egypt in 1998, where he then joined the department of Neurosurgery, Alexandria faculty of medicine as a resident, then he became an assistant lecturer in 2003, and then appointed a lecturer position in 2010. Dr. He had his Masters (2003) and MD degrees (2010). He received training and worked in several hospitals in Alexandria and also abroad. He had a fellowship at Keio University, Tokyo, Japan in 2005, also a fellowship in Interventional Neuroradiology at Fondation Ophthalmique Adolphe de Rothschild, Paris in 2007, and a research fellowship in Barrow Neurological Institute, Phoenix, Arizona 2008 to 2009. His research interest is in the field of cerebrovascular and endovascular neurosurgery. He lectures to under and postgraduates in neurosurgery.
Dr. Frank Sharp is Professor of Neurology, Neuroscience and Genetics at the University of California at Davis. After obtaining his MD from UC San Diego and training in Neurology at UC San Francisco, he held faculty positions at UCSD, UCSF and University of Cincinnati. He is the recipient of over a dozen NIH grants, served on American Heart Association and NIH grant review panels, and has published over 300 peer reviewed articles. His recent work has focused on mechanisms of brain injury following ischemic stroke and hemorrhage and developing RNA based biomarkers for ischemic stroke and hemorrhage in humans.
Ischemic stroke in humans and animal models; Immunology of stroke; Blood brain barrier; Biomarkers of stroke.
Igor Grachev, MD, PhD is a Neurologist, Psychiatrist, Neuroscientist, Drug Developer, Translational Medicine/POC, Clinical Development, Medical Affairs and Imaging expert with over 20 years of extensive Pharma industry, academic and CRO biomedical research experience who has had roles of increasing responsibility and scope at MGH/Harvard Medical School, SUNY Upstate Medical University, Schering-Plough, Sanofi-Aventis, Merck, BioClinica, Merck Sharp & Dohme Corp, GE Healthcare, and Novartis Consumer Health. All his industry roles have involved the application of imaging, biomarkers and clinical neuroscience to drug development.
Dr. Grachev is a member of the Coalition Against Major Diseases (CAMD), QIBA DCE-MRI, FDG- and amyloid-PET steering committees of RSNA, ADNI and ADNI2, Society of Nuclear Medicine, International Society to Advance Alzheimer Research and Treatment and has written and co-authored over 100 clinical research scientific publications including chapters on imaging biomarkers/technologies in three books "Methods in Pain Research (CRC Press)," “Complex Regional Pain Syndrome (IASP Press)” and “Imaging in CNS Drug Development (Springer Science, NY),” and served as a Chair of Industry Scientific Advisory Board for Parkinson’s Progression Markers Initiative, Michael J. Fox Foundation.
Neurobiology of Neurodegenerative disorders (Parkinson's disease, Alzheimer's disease, Multiple Sclerosis); Insomnia (incl. PSG), OCD, Depression, Anxiety, Schizophrenia, ADHD, Migraine, Acute & Chronic Pain, Stroke and other indications; Expert in clinical biomarkers and the following Imaging modalities: PET, SPECT, and MRI (Gd-MRI, vMRI, fMRI, MRS, DCE-MRI)
Dr. Igor Lavrov received his M.D. in Medicine from the Military Medical Academy and his Ph.D. in the field of Neuroscience from the Pavlov Institute of Physiology in St. Petersburg, Russia. After completing two Postdoctoral Research Fellowships at the University of Louisville in Louisville, Kentucky, and at the University of California,Los Angeles (UCLA) in Los Angeles, California, he was working as a junior faculty at UCLA and later as an Associate Professor at Kazan Federal University. In 2015 he joined the Department of Neurosurgery at the Mayo clinic. Over the course of more than fifteen year’s career in biomedical research, participated and lead on the research projects in spinal cord injury and neurorehabilitation, neural circuits and basic neurophysiology. The scope of his research includes studies on the role of NMDA receptors in activity of the spinal cord circuitry (at the University of Louisville), studies on sensorimotor integration in the spinal cord, on both cellular (at the University of Louisville) and systems (at the UCLA) levels, developing new methods for facilitation of neuronal circuits with electrical stimulation and pharmacological interventions (at the UCLA, Pavlov Institute of physiology, and Kazan Federal University). The results of this research were critical for the development new methods for the rehabilitation of spinal cord injured patients using the functional stimulation of the spinal cord and pharmacological approaches. The ongoing success of these therapeutic techniques currently is leading to the establishment ofnew perspective for control of posture and locomotor movements after spinal cord injury.
His research interests are focused on neuronal circuits, their modulation, reorganization, and repair after traumatic injury and on understanding of the four key principles of neuronal repair: (1) protecting surviving neurons from the secondary injury, (2) stimulating regrowth of axons and their reconnections, (3) activating neuronal circuitry with pharmacology and electrical stimulation, and (4) retraining neural circuits to restore motor functions.
Dr. Aage R. Moller has a medical degree (D. Med. Sci.) from the Karolinska Institute (School of Medicine) in Stockholm, Sweden where he spent 13 years in the position of “Docent” (Assistant Professor). After that he immigrated to the USA 1977 to take a position at the Department of Otolaryngology, University of Pittsburgh School of Medicine, and later at the Department of Neurological Surgery. He spent 19 years doing research and teaching, most recently in the position as Professor of Neurological Surgery(tenured). He moved to Dallas, Texas, 1997 to take a position at The University of Texas at Dallas where he had the Endowed Margret Fonde Jonsson Professorship in Cognition and Neuroscience in the School of Behavioral and Brain Sciences and later (2013) he was awarded the Founders Professorship of The University of Texas at Dallas.
He is the (single) author of seventeen professional books on different topics within neuroscience, hearing and intra operative neurophysiologic monitoring. He is co-editor of nine published professional books, author or co-author of 203 articles in refereed journals, and the author of 107 book chapters. He was editor-in-chief and founder (1978) of the international journal, "Hearing Research" (resigned 2005). He is the member of editorial boards of many international journals. He is especially interested in neural plasticity and its role in creating symptoms of diseases such as some forms of tinnitus and central neuropathic pain. He is Chairman of the Board of Directors of the Tinnitus Research Initiative Foundation, TRI an international organization based in Regensburg, Germany and USA.
Hemi facial spasm, spasmodic torticollis and tinnitus; Pathologies of certain neurological disorders
neuroplasticity; Role of neuroplasticity in creating and maintaining diseases such as chronic neuropathic pain and some forms of severe tinnitus; Trauma including strokes
Dr. Ahmad Sameer Mahmud Nadeem is a Physiologist doctor (holding MBChB-1988, MSc Physiology-1993 & PhD Physiology/Neurophysiology-1999) with 25 years professional clinical medical service, health education- medical teaching and research experience. He has worked for the College of medicine, Physiology department- Baghdad University for more than 15 years as a member of the teaching staff (lastly as an Assistant Professor of Neurophysiology) lecturing and supervising under as well as post graduate medical and dental students, demonstrating applied physiology laboratory techniques and doing research work. Being interested in neuromuscular, sensorimotor physiology and higher control of voluntary movement and trained in clinical neurophysiology, He was also performing clinical applied neurophysiological procedures to in and outpatients attending the clinical neurophysiology unit-Baghdad teaching hospital, the Medical City, Baghdad-Iraq. He left Iraq in 2005 to UAE and worked as Senior Specialist Neurophysiologist- Leader of Clinical Neurophysiology Unit, Rashid Hospital, Neurology Department, Dubai; performing and interpreting all clinical neurophysiology investigations, In addition to lecturing and training residents and junior doctors about neuromuscular physiology and electroneurodiagnostic testing; as well as intraoperative neurophysilogic monitoring (IOM) for patients undergoing neurosurgeries (Peripheral nerves, spinal cord and brain surgeries).
Neurophysiological studies of the neuromuscular system (particularly axonal excitability/ electrical properties of cells and the development of membrane potentials across biological membrane) that investigate the normal development and maturation of the central and peripheral nervous systems; as well as understand the neuronal basis of disease and the underlying pathophysiology in patients with neurological disorders; Sensorimotor physiology and higher control of voluntary movement of the body with the relevant sensory information/ proprioception, and its alteration in neurodegenerative diseases (e.g., Parkinson's, Alzheimer's disease and in motor neuron disease as amyotrophic lateral sclerosis ALS and Spinal Muscular Atrophy SMA); Muscle physiology and its disease processes, diseases of interest include muscular dystrophy and other congenital myopathies, diabetes and obesity.
Dr. Eduardo Garcia is a graduate of the University of Monterrey School of Medicine in Monterrey, Mexico. He completed his residency training in Neurology at Boston Medical Center in Boston MA and fellowship in Clinical Neurophysiology/ Epilepsy at the Cleveland Clinic Foundation, Cleveland OH. He is a Diplomate of the American Board of Psychiatry and Neurology (Neurology and Clinical Neurophysiology). He is a consultant neurologist at Newton-Wellesley Hospital in Newton, MA and Associate Director of the Neurophysiology Lab at Newton-Wellesley Hospital. He is Principal Investigator in several multicenter clinical trials in the area of epilepsy therapeutics. He is Assistant Clinical Professor of Neurology at Tufts University School of Medicine. He serves as Chairman of the board at The Epilepsy Foundation New England, and is President elect at the Massachusetts Neurological Association's Executive Committee
Epilepsy therapeutics; Continuous EEG; Epilepsy care
Kejie Yin is currently an Assistant Professor at the Department of Neurology of University of Pittsburgh School of Medicine. His research focuses on investigating the functional importance and molecular mechanisms of non-coding RNAs (microRNAs, long non-coding RNAs) and Krüppel-like transcription factors in the cerebrovascular endothelial pathophysiology (BBB disruption, Vascular and parenchymal inflammation, Angiogenesis) following ischemic stroke and traumatic brain injury.
Dr. Yin has been a principal investigator for multiple NIH/NINDS R01 and AHA grant awards. He has published 3 book chapters and more than 50 peer-reviewed original articles, and has served as a peer-reviewer for over 15 scientific journals. He also serves on several grant study sections for the American Heart Association (AHA).
Molecular mechanisms of non-coding RNAs (microRNAs, long non-coding RNAs)
Dr. Manuel Dujovny received his medical degree at the prestigious National University of Cordoba, the third oldest University in the American continent. He has been very active in clinical and central neurosystem research and contributed to more than 400 clinical research publications on neuroscience.
After graduating from the National University of Cordoba, he completed residencies in Neurosurgery both in Argentina and Israel under the direction of Professors Federico J. Viñas and Harden M. Askenasy respectively.
In 1973, he accepted a position at the University of Pittsburgh as Professor of Neurosurgery and Director of the Neurosurgical Research. During this time he was also Chief of Neurosurgery at the Oakland Veteran’s Administration Medical Center and a staff member of the Presbyterian University Hospital, Montefiore Hospital and Children’s Hospital Pittsburg.
In 1981 he transferred to Henry Ford Hospital in Detroit in the position of Vice-Chairman and Director of Research in the Department of Neurosurgery. In 1991 he accepted the position of Professor of Neurosurgery, Associate head and Vice-Chairman of Department of Neurosurgery at the University of Illinois at Chicago. He returned to Michigan in 1997 as a Professor of Neurosurgery at Wayne State University. He also held a position as Professor of Neurosurgery at the National University of Cordoba, Argentina and Professor of Neurosurgery to Tashkent, Uzbekistan.
Dr. Agostino Palmeri, M.D., Ph.D., is an Associate Professor of Physiology at the University of Catania (Italy). He is currently Dean for the School of Medicine and Dean for the School of Nursery and Obstetrics of the University of Catania.
In 1983 he graduated in Medicine and Surgery (University of Catania) and in 1987 he completed his Residency School in Neurology. After his PhD in Applied Biomedical Sciences (1992) at University of Catania, he obtained a post-doc position at the University of Fribourg (Switzerland).
His research is focused on Neuroscience and in particular on the field of learning and memory and Alzheimer’s disease by electrophysiology, behavioral and morphological studies. In the last 10 years, he has been studying the role of nitric oxide/cGMP pathway in synaptic plasticity and the physiological and pathological role of beta-amyloid peptide in hippocampal plasticity and memory.
In the last 2 years, he also started to explore the role of the adhesion molecule F3/Contactin in hippocampal neurogenesis, synaptic plasticity and memory in adult and aged mice.
He has been actively involved in research and he is author of several articles in international peer-reviewed journals.
He is member of several committees and reviewer for the Italian Ministry ofScientific Research, the Alzheimer's Society and the Alzheimer’s Association.
Functional role of beta-amyloid in synaptic plasticity and memory.
Protective role of phosphodiesterase-5 inhibitors on hippocampal synaptic plasticity impairment induced by amyloid-beta peptide.
Protective role of nitric oxide against impairment of synaptic plasticity induced by amyloid-beta peptide.
Dr. Gustavo J Rodriguez, M.D. was the first interventional neurologist to graduate from ACGME accredited fellowship in Endovascular Surgical Neuroradiology. He is currently Associate Professor and Vice-Chair of the Neurology Department at Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine in El Paso, Texas.
Dr. Rodriguez graduated from the University of Santiago de Compostela, School of Medicine, Spain in 1996. After completing his residency training in neurology at the Xeral-Cies Hospital in Spain, he moved to the United States for additional training, completing neurology training at the University of Medicine and Dentistry in New Jersey, followed by Vascular Neurology and Endovascular Surgical Neuroradiology Fellowships at the University of Minnesota. He is board certified in Neurology, Vascular Neurology (ABPN) and Critical Care Neurology (UCNS). His interests include Endovascular Treatment of Acute Ischemic Stroke and Intracranial Aneurysms. He has been actively involved in research and counts with numerous publications in peer reviewed journals.
Dr. Mohamed Mohi Eldin is a Professor of neurosurgery at Cairo University, Egypt. He is currently living in Giza in Egypt where he works as a consultant neuro & spine surgeon. He is member of several committees and is also member of the referee committee of the Egyptian Universities Promotion Committees (EUPC), Egyptian accreditation council for assigning neurosurgery university staffs. He is a board member of the Egyptian Society of Neurological Surgery (ESNS); administrative & board Member of the Egyptian Neurospine Group of ESNS; administrative & board member of Pan Arab MIS Society (PAMISS); member of AO Spine (Middle East); member of the Congress of Neurological Surgeons (CNS); member of the American Association of Neurological Surgeons (AANS); member of the Neurosurgical Society of Australasia (NSSA) and member of The Association for Ethical Spine Surgeons (AESS), USA.
He was graduated from Cairo University in 1987 where he then pursued his Masters (1992) and MD degrees (1997). He received training and worked in several hospitals in Egypt and also abroad. His research interest is in the field of microsurgery and spine. He lectures to under and postgraduates in neurosurgery and spine interventions.
In the last 10 years, he is dedicated to minimally invasive spine philosophy, interventions and surgeries. Following, his many studies addressed the complications of conventional spine surgeries; he started a campaign for educating professionals, patients and the public about minimally invasive spine philosophy, interventions and surgeries in spine diseases which are involved in educational, research, and clinical components. He is also the author of several books and writings.
Brain and Spine tumors: Surgical treatment and outcomes, molecular biology (mostly microRNAs in brain tumors), management and neurocognitive changes in patients with brain tumors. Furthermore my interests include blood-brain-barrier changes in CNS pathology, specially in tumors and trauma.
Ismail Hakkı AYDIN, MD, Professor of Neurosurgery, was born in Maçka, Trabzon, Turkey on 1954.He received his medical degree at the Ataturk University of Erzurum, the fourth oldest University in the Turkey. After graduating from the Medical School, he completed residencies in Neurosurgery in Atatürk, Istanbul and Zurich Universities.
In 1984, he accepted a position at the Ataturk University of Turkey as Ass. Professor of Neurosurgery and Director of the Neurosurgical Department of Medical School, and received full Professor of Neurosurgery in 1994. His chairmanship in this Department was very active untill 2010. After this time, he transferred his position to a private University in Istanbul.
He, who was the past President of the Nervous Systen Surgery Society, has some neurosurgical thecniques and Sylvian Vein and Cistern Classification were published. For his reason he received more than thirty national and international prestigious awards in Neurosurgery.
He has been very active in clinical and central neurvou system research and contributed to more than 150 clinical neurosurgery, microneurovascular, surgical thecniques and experimental research publications on neuroscience. Also, He is the Honorable and Invited Guest Lecturer of Scientific Congress in the many countries of the World.
He is the Editorial Board of many Scientific Journals, and Active Member of more than twenty Neuroscientific Societies, including Congress of Neurological Surgeons (CNS), American Association of Neurological Surgeons (AANS), American Heart Association (AHA) and European Stroke Science Councile. Also, Prof. Dr. Ismail Hakki AYDIN is the Iternational Ambassador of CNS since 1999.
Prof. Mevludin Hasanovic is Associate Professor and neuropsychiatrist, subspecialist of social psychiatry and group analyst. He graduated on the Sarajevo University School of Medicine (1982). He completed Specialization and Postgraduate study at the Zagreb and Tuzla Universities. He obtained his PhD and associate professorship in 2009 from the University of Tuzla. He teaches in University of Tuzla on Medical School and on Educational and Rehabilitational School, also on University of Zenica, School of Social Pedagogy. He is one of founders of Tuzla users’associations: Fenix, Nada (Hope) and Stecak. He is member of Editorial board of journals “Acta Medica Saliniana” and “Acta Medica Academica”; Secretary of 6th International Congress of World Islamic Association for Mental Health (WIAMH), 1999, Tuzla, BH; General Secretary of the 3rd Congress of Psychiatry Association in Bosnia and Herzegovina with International Participation 2012 in Tuzla, BH. The professional title “Primaries” acquired 1994. President of Tuzla Canton Psychiatry Association (2011-) and President of Association of EMDR practicioners in Bosnia and Herzegovina (2013-), also he is Secretary of Association for Integrative Medicine in Bosnia and Herzegovina (2014-). Awarded with second Prizes for the best scientific paper published in 2005, 2006 and 2012/2013 year in University Clinical Center Tuzla. He is graduated Group Analyst and Educator, also he is an European Accredited EMDR Practicioner. He published more than 200 scientific and professional papers in the field of psychiatry and mental health care in the International Journals, Congress publications and as book chapters in the national and international books and textbooks. He established medical assisted treatment of heroin addicts with buprenorphine+naloxone (Suboxone) method in BH. He coordinates education in Eye Movements Reprocessing and Desensitisation (EMDR) education in BH. He coordinated several international research projects.
Clinical aspects of psychosocial trauma; Family medicine; Traumatic stress syndrome; War veterans and civilian victims of war as well as children and adolescents; The role of spirituality and religiosity in the promotion and preservation of mental health and clinical methods of EMDR; Neuroimaging of brain cortex; Opiate substitution treatment with buprenorphine+naloxone (Suboxone).
Dr. Dezena is graduated in Medicine at Federal University of Triangulo Mineiro, Uberaba, Brazil (2003). He completed his residency training in Neurosurgery at Santa Casa de Misericórdia de Ribeirão Preto, Brazil (2009), and achieved his Ph.D. in Neurosurgery at Ribeirão Preto Medical School of University of São Paulo, Brazil (2011). In Brazil, he is Full Member of Brazilian Society of Neurosurgery (SBN) and Brazilian Academy of Neurosurgery (ABNc). Internationally, he is Fellow of World Federation of Neurosurgical Societes (WFNS), Visiting Fellow of University of Tübingen, Germany, and Full Member of Latin American Federation of Neurosurgery Societes (FLANC) and Latin American Group of Studies in Neuroendoscopy (GLEN). Currently act as Clinical Chief and Assistant Neurosurgeon of Division of Neurosurgery of Clinics Hospital, Federal University of Triângulo Mineiro, Uberaba, Brazil, in neurosurgical activities, clinical care, teaching and research activities. Furthermore he is Postdoctoral Fellow at the same university. He is Editorial Board Member of International Journal of Anesthesiology Research (Phaps) and reviewer of online scientific journals.
Dr Shakir Husain graduated from The RNT Medical College, Udaipur in 1986, completed residency in Internal Medicine at the same Institute to obtain MD (Internal Medicine) in 1991. He joined a post-doctoral program in Neurology at G B Pant Hospital & Maulana Azad Medical College, New Delhi to obtain DM (Neurology) from Delhi University in 1995. He worked at GB Pant Hospital as senior research associate in the Department of Neurology and as a neurologist at St. Stephen's hospital, Indraprastha Apollo Hospital and VIMHANS in New Delhi before leaving for Zurich for a Fellowship in Interventional Neuroradiology in 1997.
He completed fellowship in Interventional Neuroradiology at the Institute of Neuroradiology, University Hospital Zurich, Switzerland in 1999. He had visiting fellowships in Interventional Neuroradiology at Fondation Ophthalmique Adolphe de Rothschild, Paris and University Hospital Eppendorf, Hamburg, Germany. He worked as a Consultant Neurologist & Interventional Neuroradiologist at Sir Ganga Ram Hospital, New Delhi, India from May 1999 till October 2009, where he developed one of the first departments of Neuroendovascular Therapy in the country. He developed a structured one year "Egas Moniz Fellowship in Interventional Neurology" and trained more than 18 fellows over 5 years period. In 2009 he joined Max Group of Hospitals as the Director of Interventional Neurology and Director of Max Stroke Program where he was actively involved in developing an independent Neurointerventional service with an integrated Day care, Interventional Stroke ICU and Neurovascular Suit. He moved to Saket City Hospital on 1st Feb 2014 to join the Institute of Neurosciences as a director, Interventional Neurology & Stroke and Chairman, department of Neurology with a desire and commitment to create a comprehensive care system for the Stroke victims and create a state of art Neurointerventional program.
Cerebral AVM and embolization, Dural AVF embolisation, Intracranial atherosclerotic disease, dissection of cranial vessels, Venous sinus thrombosis, Endovascular Intervention in acute stroke, aneurysm coiling, carotid disease, Moya Moya disease.
Dr. Qiyong Gong is presently the Professor of Neurology, Psychiatry and Radiology at the Sichuan University Hospital, China, and the Visiting Professor of both the Yale University and the Universityof Illinois Hospital & Health Sciences System, USA. He is the Vice President of the West China Hospital and the Deputy Dean of the West China School of Medicine, both at Sichuan University. He is also the Founding Director of Huaxi MR Research Center (HMRRC) of the University Hospital, and the Deputy Chair of the MR academic committee of the Chinese Society of Radiology. Hs research interests mainly involve MR imaging and image analysis including morphometry, tissue characterization, spectroscopy and fMRI. His translational research interest was previously the development and the application of MR quantitative method in neuro-abnormalities, and in the past five years, has been in imaging characterization of the mental health problems, specifically the psychiatric imaging and psycho-radiology. So far, he has published over 220 peer-reviewed SCI articles including those, as the leading author, on PNAS, Arch Gen Psychiatry, Am J Psychiatry, Biol Psychiat, Radiology, MRM, NeuroImage and Hum BrainMapp. His research articles published in the recent 5 years have received over 4000 citations, and he has given a number of Invited/Keynote Lectures to and also acted as the session moderator or chair at major international conferences, including the invited lectures to major institutions such as Harvard University and Yale University. In addition, He reviews for a number of leading journals on radiology, brain and behavioural sciences, as well as neuro-psychiatry, amongst them Radiology,NeuroImage,Hum Brain Mapp, Brain, Neurosci BiobehavR, Arch Gen Psychiat (JAMA-Psychiatry), Am J Psychiat, Biol Psychiat, etc. He was awarded the American CMB Distinguished Professorship (administered by the Institute of International Education, USA) in 2010. He is an Associate Editor for Frontiers in Neuropsychiatric Imagingand Stimulation (NPG online open access journal), an Academic Editor of PLoS ONE, an Editorial Board Member of World Journal of Radiology and he is also the appointed member of both Subcommittee on the Young Investigators’ Awards and Education Committee for International Society for Magnetic Resonance in Medicine .
Randy Beck is the Executive Director of the Institute of Functional Neuroscience in Perth, Australia. The Institute of Functional Neuroscience has clinics located in Sydney, Melbourne, Perth, Australia; HongKong and London, Canada.
He is currently a Professorin Clinical Neurologyat the Carrick Institute for Graduate Studies in Florida, USA. He was previously Senior Lecturer in Neurology and Clinical Diagnosis at Murdcoh University in Perth. He is the past President of the Australasian Academy of Functional Neurology and has served as a director since 2006.
Dr Beck graduated from The University of Western Ontario, London and Canadian Memorial Chiropractic College, Toronto, Canada. He subsequently completed a PhD on Psychoneuroimmunology. He has been involved with post-graduate and undergraduate education of healthcare professionals for over 15 years.
He has authored several textbooks, published by Elsevier. The first and second texts entitled Functional Neurology for Practitioners of Manual Therapy and Functional Neurology for Practitioners of Manual Medicine remain the pivotal foundational texts in the field. He has also authored numerous textbook chapters, journal articles and reviews in peer-reviewed journals.
He is the recipient of the prestigious Excellence in Teaching award from Murdoch University and the International Association of Functional Neurology, Rehabilitation and Ergonomics Neurologist of the year award. He is a frequent speaker at both international and national conferences, seminars and workshops.
Dr. J. Lucas Koberda is a board certified neurologist and an internationally trained physician who completed his residency in Neurology at the Oregon Health Sciences University in Portland, Oregon. Prior to his neurological training, he received his Ph.D. based on his research in the area of tumor immunology.
He is currently in private practice and is affiliated with The Florida State University College of Medicine. He was appointed in August, 2010 by Governor Charlie Christ as a member of the Alzheimer’s disease Advisory Committee. He has published multiple publications in different scientific journals and serves as international neuroscience speaker and consultant.
Dr. Rosenfeld is specialized in Physical Medicine and Rehabilitation (“PM&R”) with particular interest in the treatment and neurorehabilitation of central and peripheral neurological conditions, including stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, neuropathy, and pain. Furthermore, he also is a practiced attorney, with nearly 25 years of experience in the areas of FDA regulation and strategic clinical and regulatory consulting for numerous technologies (including medical devices, biotechnologies, and pharmaceuticals), many of which are intended for use to diagnose or treat neurological dysfunction. He routinely provides analysis and direction with regard to medical investigators’ and sponsor companies’ complex clinical and regulatory issues at all stages of product development, and he interacts with the relevant U.S. and international agencies in these respects. From a research perspective, He has been central to the design, implementation, and oversight of clinical trials involving the evaluation of treatments for a broad range of neurological diseases and injuries. In this respect, he has authored numerous peer-reviewed journal articles, as well as multiple abstracts and other publications, and he has been a featured speaker on a variety of clinical and regulatory topics. He obtained his PM&R residency training from the Rehabilitation Institute of Chicago after attending the Medical College of Virginia, and he received his legal education at the University of Pennsylvania Law School. Dr. Rosenfeld also has a BA in Neurobiology from Harvard College. He is a fellow of the American College of Legal Medicine.
Physical Medicine and Rehabilitation (including stroke, traumatic brain injury, spinal cord injury, pain [central/peripheral], neurodegenerative and other CNS/PNS conditions, mobility disorders, general neurology.
Dr. Rahul T. Chakor is Head of the Department of Neurology at the T N Medical College and B Y L Nair Hospital, Mumbai, India. He is also a consultant Neurologist at the Prince Aly Khan Hospital and Saifee Hospital Mumbai. He is Professor of Neurology at the Maharashtra University of Health Science, India. He is actively involved in teaching neurology to medical students and residents.
He completed his Neurology training at the Bombay Hospital Institute of Medical Sciences. He worked as a Research Fellow in Clinical Neurophysiology at the Cleveland Clinic Epilepsy Centre in the year 2007-8.
He has received the Maulana Azad award (2012) for outstanding contribution in the field of Medical Profession & Human Service from the MRCC, Minority department. He received the Hargobind foundation medical fellowship for the year 2007.
Dr Chakor has authored articles in leading peer reviewed journals. He is a reviewer for neurology journals and is on the editorial board of scientific journals.
He is a Principal investigator for several phase II/III clinical research trials on Epilepsy, Stroke, Multiple Sclerosis and Parkinson’s disease.
Treatment of acute stroke,
Tokyo Metropolitan Institute of Medical Science
Serdar Kahraman is a Professor of Neurosurgery at a private foundation university in Istanbul-Turkey. He is active president of Turkish Spine society for 2013-2015. He has a duty for membership committe in Eurospinesociety. His clinical interests include spine surgery, neuroendoscopy, neurovascular diseases and brain tumors. He had a training for neuro and spine endoscopy in Germany in 1998. He has been working as editorial board member of many national and international journal. He has published several articles and book chapters in various journals. Also he has a many presentations in meetings.
Spinesurgery, Neuroendoscopy, Braintumors and Neurovascular disorders.
Dr. Eugene Golanov, M.D. Ph.D., graduated from the oldest Russia medical school, I.M Sechenov Moscow Medical School (now I.M. Sechenov First Moscow State Medical University) with summa cum laude. Since his student years he actively pursued research in neuroscience studying mechanism of autonomic regulation and pain. After graduation he continued his research at the Institute of Normal Physiology in Moscow. Within two years, he successfully defended doctoral thesis on the mechanisms of endogenous pain regulation. Soon after that, Eugene moved to All Union Cardiology Research Center (Moscow), where he led research group studying central mechanisms of blood pressure regulation, neurogenic hypertension, and endogenous opioid system combining clinical and experimental research including primates. He continued his career as a neurophysiologist at the Division of Neurobiology at Weill Medical College of Cornell University (New York) studying central regulation of cerebral blood flow, endogenous neuroprotection and stroke. After over a decade at Cornell University, Eugene Golanov moved to the University of Mississippi Medical Center, where, as a full professor, he led a research division of the Department of Neurosurgery. His work addressed integrative and molecular mechanisms of neuronal damage and neuroprotection. There he initiated pioneering work unveiling naturally occurring neuroprotection. Later, Eugene Golanov served as a stroke program manager at the National Institute of Neurological Diseases and Stroke/NIH and as a subject matter expert in traumatic brain injury and neuroscience portfolio manager at TATRC/US Army Medical Research and Materiel Command. In a few years, Eugene decided to resume academic career and headed the research group of the Department of Neurosurgery at the North Shore Hospital in Long Island, New York, where he continued his work in innate neuroprotection and participated in studies of neurogenic regulation of immunity. For the last two years Eugene is leading cerebrovascular laboratory of the Department of Neurosurgery at the Houston Methodist Hospital/Weill Medical College of Cornell University. Eugene Golanov published over 70 peer-reviewed papers in various areas of neurophysiology in animals and humans on brain damage, neuroprotection; pain and endogenous analgesia; endogenous opioid system; circulatory shock; regulation of autonomic functions, including regulation of peripheral nervous and cardiovascular systems, neurogenic arterial hypertension, regulation of cerebral blood flow, stroke, and epilepsy.
Neurophysiology in animals and humans on brain damage; Neuroprotection; Pain and endogenous analgesia; Endogenous opioid system; Circulatory shock; Regulation of autonomic functions, including regulation of peripheral nervous and cardiovascular systems; Neurogenic arterial hypertension; Regulation of cerebral blood flow; Stroke; Epilepsy
Dr. Gerard Rosse is Associate Director at Dart Neuroscience, San Diego, CA. He also serves as Adjunct Associate Professor at Drexel University and Adjunct Professor of Medicinal Chemistry at the Pennsylvania Drug Discovery Institute, Philadelphia, PA. He is a medicinal chemist with expertise in the discovery and development of small molecules and peptides drugs for a wide range of therapeutic indications including cancer and CNS. He functioned in management and scientific positions in medicinal chemistry with Cephalon, Sanofi and F. Hoffman-La Rocheis. Hiscareer is characterized by the implementation of innovative chemical technology platforms that accelerated the drug discovery process and reduced costs. He is a distinguished speaker at business meetings in US and Europe. He is member of many editorial boards of journals and serves on scientific review board of neuroscience research organizations.
Novel drug discovery technologies;
PET ligands, Mitochondrial dysfunction;
G-protein coupled receptors and protein-protein interaction;
Traumatic Brain Injury;
Petr Galkin, M.D., Ph.D., is a Research Officer of Neurosurgery Department of Research Center of Neurology, Moscow, Russian Federation.
He graduated in 1996with Diploma with Highest Honors (“Summa Cum Laude”) and Doctor of Medicine Degree from Sechenov First Moscow State Medical University. He completed his residency training in General Surgery at General Surgery Chair of Sechenov First Moscow State Medical University (1998) and achieved his Ph.D. in Vascular Surgery at Russian Research Center of Surgery, Moscow, Russian Federation (2001). In 2001 he occupied a position of vascular surgeon at the Department of Neurovascular Surgery of VishnevskyThird Central Military Hospital, Krasnogorsk, Moscow region, where he started his vascular and neurosurgical, same as research career. He is a winner of thesis competitions among young neurosurgeons at the Fourth Russian Neurosurgical Meeting, Moscow, June 2006 and Sixth All-Russian Scientific-Practical Conference “Polenov’s Readings”, Saint Petersburg, April 2007. In 2007, after completion of professional retraining at Neurosurgery department of Russian Medical Academy of Post-Graduate Training of Physicians, Moscow he was certified as neurosurgeon by Russian License Board. In 2010 He moved to Research Center of Neurology where he started research activity in field of surgical revascularization of the brain on purpose to prevent ischemic stroke.
He published numerous scientific articles pertaining to the fields of vascular and neurosurgery.
He is the experienced surgeon in management of carotid atherosclerotic disease (including multiple stenosis/occlusions of brachiocephalic arteries), moya-moya disease, brain aneurysms, arteriovenous malformations, brain tumors (meningiomas, gliomas, vestibular schwannomas) and non-traumatic intra cerebral hemorrhage with the employment of modern minimally invasive techniques such as navigation and endoscopy. He also performs surgeries for spine tumors, different spinal degenerative conditions, as well as for peripheral nerve diseases.
Brain micro revascularization (STA-MCA bypass) in moya-moya and carotid occlusion patients; High-flow bypass surgery in complex brain aneurysms; Medical care in stroke patients with the use of minimally invasive (endovascular, endoscopic) surgical interventions.
Dr. Frank is Research Director and Professor in Drug Discovery and Academia. Frank has made significant contributions to discovering drugs, to increasing the understanding of drug action and to the biology of several diseases. Scientific, management and communication skills have been utilized to establish a long-term record of building functional, cohesive research teams that are empowered to meet and exceed their research goals. Specifics include:
25 years in Drug Discovery functioning as research team leader in developing and executing research strategies from target discovery to drug screening and target validation in disease to marketed drug and post-market drug scientific support; History of maintained/consistent research/resource support in industrial environment for disease target research and compound progression in Discovery Research; Recent experience building a new laboratory and maintaining its support and mentoring undergraduate, graduate and Medical students in Graduate and Medical schools in an academic environment. Specifically:
· Significant experience as consultant to Pharmaceutical Companies and in the academic work environment helping to developing research direction, helping to secure federal research grant support and teaching.
· Ability to Integrate Systems Pharmacology/Biology and Translational Medicine into Drug Discovery and Disease Biology Research.
· Long standing research background/experience in cardiovascular and cerebrovascular diseases with current focus on cerebrovascular Disease-Stroke and Vascular Cognitive Impairment
Member of journal editorial boards and NIH study groups; scientific reviewer to many journals, granting organizations and study groups/sections; member of numerous scientific societies; four faculty appointments; currently have published over 200 scientific manuscripts, reviews, chapters and patents.
Cerebrovascular Diseases; Stroke; Vascular Cognitive; Impairment; Dementia; Sensory Motor Behavior; Cognitive Behavior; Restoration of Function; Growth Factors; Brain Protection; Brain Recovery from Injury
Russell Hanson was born in Palo Alto, CA on May 2, 1981 and grew up in California and Bloomington, IN. From 1999--2003 he studied in Portland, Oregon at Reed College, completing a bachelor's degree in Physics. In 2005 he received an M.S. in Biology from Georgia Tech and his PhD studies were in Chemistry at Boston University. His research interests are varied and span machine learning and statistical learning theory, neuroinformatics and connectomics, chemical engineering, biophysical and medicinal chemistry, cancer and cancer biology, quantitative finance, algorithmic trading and technology, synthetic biology and computational biology, quantum computation and information, natural language processing and mathematical logic and recursion theory. Past academic appointments include Harvard, MIT, the Chinese University of Hong Kong, and the Technical University of Berlin. An entrepreneur and businessman, in 2008 he foundedSciColab.com a collaborative website for scientists and researchers, co-founded LobeLink.com a web annotation and recommendation engine company, founded Reducible Systems, Inc a quantitative consulting company, and in 2009 co-founded TagHalo.com a word tag cloud-based information browsing/search system. He serves as Chairman of the Committee on Advanced Technology with the US national non-profit The Cure Is Now. Russell Hanson consults regularly with innovative companies with a variety of needs.
Dr. Beatrice Mihaela Radu is Research Associate in the department of Neurological and Movement Sciences, University of Verona, Italy and Lecturer at the Department of Anatomy, Animal Physiology and Biophysics, University of Bucharest, Romania. She is currently living in Verona, Italy, where she is involved in several research projects. She is an editorial board member of Frontiers of Biological and Life Sciences (Sciknow) and Journal of Clinical and Experimental Neuroscience (Sciknow), and advisory board member of Neuroscience Research Letters (BioInfo), and member of the International Society for Cerebral Blood Flow & Metabolism (ISCBFM), member of International Society of Neurochemistry (ISN), member of the International Association for the Study of Pain (IASP), member of the American Society of Cell Biology (ASCB), member of the European Association for the Study of Diabetes (EASD), secretary for Bucharest’s branch Romanian Society of Pure and Applied Biophysics (affiliated to EBSA and IUPAB), member of Romanian Society of Biochemistry and Molecular Biology (affiliated FEBS), member of the National Neuroscience Society (affiliated FENS and IBRO). She is reviewer for the Journal of Ethnopharmacology (Elsevier), Journal of Fluorescence (Springer), Journal of Cellular and Molecular Medicine (Wiley).
Dr. Beatrice Mihaela Radu was graduated from the University of Bucharest, Faculty of Physics in 2001, where she obtained her Masters in Neurobiology (2003) and PhD in Biology degrees (2005). Her research interest is in the field of epilepsy, pain and neuropathic pain, investigation on animal models by means of electrophysiological techniques. She had long-term trainings in prestigious European laboratories from the INSERM (Paris), Cajal Institute (Madrid), University of Verona (Verona) and University of Bucharest (University of Bucharest). She lectures at the Master of Neurobiology at the University of Bucharest, providing training to postgraduates in basic and advance techniques used in neurosciences.
In the last 10 years, she dedicated her research to uncover the molecular mechanisms of diabetic neuropathy in type 1 diabetic mouse models, with a special focus on sensory neurons from dorsal root ganglia. In the last 3 years, she started to explore the role of brain microvascular endothelium in epileptogenesis. She is author of multiple articles in peer-reviewed journals.
Prof. Sanjay Pratap Singh is the Chairman & Professor of the Department of Neurology at Creighton University School of Medicine. He is also the Medical Director of Neurological Services at Alegent Creighton Health-Creighton University Medical Center. One of the youngest Chairman of a Neurology Department in North America. He is also currently the Chief of Staff of Creighton University Medical Center. He has been awarded the Best Doctors in America for 2012 & 2013.
Earlier he was the Vice Chairman (Education) at University of Nebraska Medical Center (UNMC). He was also the founder Director of the The Nebraska Epilepsy Center at UNMC. He has also served as the Program Director of the Creighton-Nebraska Joint Neurology Residency Program.
He received his medical degree from M.L.N. Medical College in India, where he was the Valedictorian of his class. He completed a neurology residency at George Washington University Medical Center; he was the Chief Resident of Neurology in his PGY-4 year. He then did a two year fellowship in Epilepsy and Clinical Neurophysiology, as the Gilbert Glaser fellow, at Yale University School of Medicine. He is Board certified in Neurology and is a member of the American Academy of Neurology and the American Epilepsy Society.
He is the author of the 'Locatelli & Singh's Handbook of Neurology'. He is the author of numerous articles and also a few Book Chapters. He has been the recipient of numerous awards and honors including the A.B. Baker Teacher recognition award by the American Academy of Neurology, The UNMC Chancellor's Gold U Award & Kudos award of the Board of Regents award for University of Nebraska.
He has been invited to Lecture at many national and international institutions and conferences. He has also given talks to the community in 'Science Cafes & Simply Science' programs.
Dr. Alfio Spina is a neurosurgery resident at the Department of Neurosurgery and Gamma Knife Radiosurgery, San Raffaele Scientific Instituete Vita Salute University in Milan. He participated as relator in many conferences about neuroncology, neurosurgery and radiosurgery. Hehas good knowledge about Neuronavigation and Image guided surgery. His fields of interest are Neuroncology, Skull base surgery, Radiosurgery. He has published articles in peer-reviewed journals.”
Jawad F. Kirmani is Director of the Stroke and Cerebrovascular Program at the NJ Neuroscience Institute at JFK Medical Center. Dr. Kirmani is also an Associate Professor, Neurology and Neurosurgery, Seton Hall University School of Health & Medical Science, South Orange, NJ. Dr. Kirmani received his M.B. B.S. at the Aga Khan University Hospital (AKUH), Karachi, Pakistan. Dr. Kirmani’s clinical activities and professional skills include but not limited to Neuro endovascular evaluation, interpretation and performance of procedures; Cerebral angiography, stroke revascularization, stent and angioplasty, embolization procedures; Neurocritical care evaluation, interpretation and performance of invasive procedures such as oral and nasal intubations, laryngeal mask airways, intraventicular catheters, swan ganz catheters, central and arterial lines, cisternal punctures, lumbar punctures, Botox injections, epidural and occipital blocks. Dr. Kirmani received the “2008 to 2012 Patient Choice Award.” Dr. Kirmani has several research activities in his area of medicine, serves on several committees and has authored numerous research and publications.
S Ausim Azizi, M.D., Ph.D. is a Professor of Neurology and Chair of the Department at Temple University School of Medicine. He is also the director of the neurological intensive care unit at Temple University Hospital. He earned his bachelor’s degree from the University of Texas and his MD and PhD degrees from Southwestern Medical School in Dallas. He completed his medical and neurology residency training at Yale University School of Medicine. He is board certified in neurology and neuro-critical care.
He is a general neurologist with a focus on neuro-critical care, neurodegenerative diseases, stroke, multiple sclerosis and movement disorders. He has been recognized by his peers as best doctors in Philadelphia and US news.
He has taught neuroscience/neurology at multiple levels, from first year medical school to continuing medical education. He has given numerous invited regional, national and international lectures. Received multiple teaching awards including a visiting professorship to the Mayo Clinic.
His current research is focused on repair and regeneration of damaged nervous system. His laboratory is exploring techniques to prepare adult derived cells for use in tissue engineering and brain repair. He has published research articles, book chapters and editorials. He is the deputy editor of Neuroscience Letters and on the editorial board of many other neuroscience journals. In addition, he is a fellow of American Neurological Association (ANA), American Academy of Neurology, American Society for Neuro-transplantation and Repair (ASNTR), founding member of American Society for Neuro-therapeutics (ASNT) and member and officer in multiple national and international neuroscience and neurological organizations.
Current basic research is focused on rehabilitation and regeneration of damaged central nervous system. We are exploring techniques to prepare non-embryonic stem cells for use in tissue engineering. We are studying the signaling pathways of differentiation of adult stem cells to generate useful neural and glial cells that could be used for repair and regeneration of the nervous system.
We are working to develop techniques for administration of adult stem cell into animal models, for treatment of stroke, Parkinson Disease and traumatic brain injury and to eventually translate these findings to clinic
We are exploring the mechanism of genesis of tumors from stem cells using novel molecular and stem cell technologies.
Clinical Trials on stroke, Multiple sclerosis and Parkinson Disease.
Dr Gianni Sorarùis Assistant Professor of Neurologyat the Department of Neurosciences of the University of Padova, Italy. He hasgraduated at the University of Padova in 1996, where he alsoattended the Postgraduate School of Neurology (2007-2000) and obtained the PhD in Neurosciences (2005). He wasresearchfellowat the Neuromuscular Unit “V. Dubowitz”, Hammersmith Hospital – Imperial College in London (1999-2000). Dr. SorarùhasworkedasNeurologistat the Neurology Unit of Piove di Sacco Hospital (Italy) from 2002 to 2006 and rejoined the clinical staff of the Department of Neurosciences of the University of Padovaafterwards. He iscurrentlyinvolved in teachingmedicalstudents and trainees in Neurology. He haspublishedover 50 articles in peer-reviewedjournals and isreviewer of scientificjournals.
Dr. Antonio Pisani is a physician-scientist with a long standing interest in the basic and clinical aspects of basal ganglia dysfunction, with a specific interest in dystonia and Parkinson’s disease. He leads the Neurophysiology and Plasticity laboratory at University of Rome Tor Vergata, in Rome, providing guidance in the planning and execution of the experiments. Since 2003-2004, he has been deeply involved in research on dystonia, focusing on the role of striatal function in the pathogenesis of this movement disorder. In detail, he focused on the functional interplay between striatal dopamine and acetylcholine, characterizing the alterations occurring in distinct rodent models of DYT1 dystonia and monogenic parkinsonisms. His long-term commitment to this field of research is witnessed by the number of peer-review publications as well as by the organization of 5 editions of an international workshop on dystonia (2007-2015). As a neurologist involved full-time in clinical practice, he’s chairing the “Neuropathophysiology Unit” of the University Hospital Policlinico Tor Vergata in Rome, and involved in movement disorders outpatient service, as well in clinical trials on Parkinson’s disease patients.
Basic and clinical aspects of basal ganglia dysfunction, with a specific interest in Dystonia and Parkinson’s disease; Neurophysiology; Neuroplasticity; Movement disorder; Neuropathophysiology.
After medical college (University of Zurich, Switzerland) Dr. Schmid worked as an officer and military doctor, fellow and registrar in internal medicine, neurosurgery and neurology in diverse major clinics, before finishing neurological education at University hospital Zurich.He then built up and led the neurology unit of an rehabilitation clinic. He specialized within the field of neurology in cerebrovascular ultrasound examinations and military medicine (neurology).
Dr. Erich W Garland is a native Texan who grew up in Beaumont. He attended Lamar University and graduated in 1978 with a BS degree in Biology and Chemistry. He then attended the University of Texas at Dallas where he studied Molecular Biology until he became interested in Medicine and entered medical school at Texas Tech University School of Medicine in 1981. He completed his medical degree in 1985 and internship in Internal Medicine at the Texas Tech University Health Science Center in 1986. He then spent 3 years at the University of New Mexico Hospital and VAMC to complete his Neurology training.
In 1989 after completion of his Neurology residency he started Northeast Texas Neurology Associates in Sherman, Texas. This was a satisfying Neurology practice for him, but was not a good fit for his family. Then he moved to his current solo practice in Idaho in 1991. Currently, he is Medical director of Idaho Falls Neurology since 1991. He practice general Neurology and provide care for both children and adults of all ages. He became board certified in Neurology in 1994. He obtained board certification in Vascular Neurology in 2009. He helped to establish the first primary stroke program and telestroke program in Eastern Idaho at the Eastern Idaho Regional Medical Center in 2011. He has been involved with teaching medical students from the University of Washington, Des Moines University School of Medicine and other medical schools for many years. I also teach students from the Pharmacy, PA and NP programs from Idaho State University on occasion. He is advocate for his patients and completed the 2014 AMPAC Candidate Workshop. He served as the Idaho Medical Association president in 2007.
Epilepsy in adults and children; Migraine headaches in adults and children; Sleep disorders; Stroke acute management and secondary prevention; Peripheral nerve disorders & Muscle disease; Multiple sclerosis; Neurorehabilitation; Parkinson’s disease and tremor; Spasticity, Dystonia and other movement disorders.
Neurological and Neurosurgical Hospital P Wertheimer
Prof. Francesco Signorelli is an Italian board certified neurosurgeon. He was trained in neurosurgery at the University Hospital of Naples, Italy. He was a fellow in neurosurgery in London and Southampton, UK, and fellow in vascular neurosurgery and skull base neurosurgery at the Notre Dame Hospital of the University of Montreal, Canada. In 2007 he was appointed as associate professor of neurosurgery at the University Hospital of Catanzaro, Italy. He has recently rejoined the staff of the neurosurgical and neurovascular department at the “P. Wertheimer” Hospital for Neurology and Neurosurgery in Lyon, France, where he is also involved in teaching medical students and trainees in neurosurgery and neuroradiology. His surgical practice has canvassed the spectrum of neurosurgery, together with his scientific activity, with over 50 articles in peer-reviewed Journals and several book chapters and review articles. He is a member of national and international neurosurgical associations and of the “Association pour le Development Medical au Vietnam”, a French humanitarian association. His current major interests are vascular neurosurgery and brain tumors in eloquent areas. Surgical and endovascular treatment of brain vascular malformations is a significant portion of his practice.
Amin El Ghanam is an assistant lecturer of neurosurgery . He had a tremendous activities and great researesh experience in stroke with special interest in endovascular treatment. Initiated a well established endovascular activities with Dr . med M. Shadad after finishing his MD program with Prof Valvanis also a strong stroke unit serving more than 15 millons people in the delta region . Egypt had been established.
Early diagnosis of stroke;
Mobile Stroke unit;
Smart devices for endovascular mangment of stroke;
Dr. Gavin W. Britz is Professor and Chairman of the Department of Neurosurgery at Houston Methodist Hospital and Co-Director of the Methodist Neurological Institute. He leads an acclaimed team of neurosurgeons and affiliated professionals and is recognized as one of the nation’s foremost cerebrovascular, skull base and brain tumor surgeons.
Dr. Britz is one of the most experienced surgeons for brain aneurysm procedures, including highly complex cases that require cardiac standstill or complex bypasses. He treats brain aneurysms using the traditional microsurgical techniques but also performs endovascular treatment with coiling and stenting of aneurysms as he has trained in both neurosurgery and interventional neuroradiology. He additionally specializes in the treatment of arteriovenous malformations, dural fistulas, arterial dissections, atherosclerotic disease, Moya Moya disease, diseases affecting the skull base and brain tumors. The brain tumors include tumors such as Meningiomas, chordomas, Pituitary tumors, craniopharyngiomas, vestibular Schwannomas, gliomas, and glioblastomas. He also performs microvascular decompressions for facial pain and Hemifacial spasm.
He came to Houston from Duke University Medical Center in North Carolina where he served as Director of the Cerebrovascular Center and Associate Professor of Neurosurgery. Earlier in his career, he was Co-Director of the Neurological Surgery Unit and Director of Endovascular Neurosurgery at Harborview Medical Center while serving as Associate Professor of Neurosurgery and Radiology at the University of Washington School of Medicine in Seattle. He leads basic science and clinical studies to understand stroke causation and evaluates novel tools to treat brain aneurysms and skull base tumors.
Dr Britz has received Best Doctor in America distinction six different years. He is on the advisory boards of the Joe Niekro Foundation and The Brain Aneurysm Foundation. He serves on the editorial board for Neurosurgery, World Neurosurgery, International Journal of Vascular Medicine, Surgical Neurology International, Dataset Papers in Medicine and SOJ Neurology. He has authored more than 90 peer reviewed scientific manuscripts and 28 chapters for various neurosurgical books.
Understanding cerebral microcirculation, including clinical research to evaluate novel tools to treat problems such as brain aneurysm and skull base tumors.
Causes of stroke and poor outcomes following ruptured aneurysms.
Dr. Khaku is a board certified neurologist licensed in the state of Florida, affiliated with the University of South Florida and the VA. He completed his undergraduate education at Lehigh University in Bethlehem, PA receiving a Bachelor’s in Biology with Highest Honors. He subsequently pursued his medical studies at the University of Rochester school of medicine in New York, graduating with an MD with Distinction in Research. He then pursued a residency in neurology completing both his internship in Internal medicine and subsequent neurology residency at the University of Florida, in Gainesville, FL. He was nominated and served as the Chief resident in his final year. He is passionate about education, research, and advocacy. He received the Resident Award for Leadership and Advocacy in Neurology in 2012 as well as the Shands Hospital Customer Service Key Award. He has presented several posters and publications at local and national meetings and has co-authored several book chapters in renowned texts
Sleep, Stroke, and ALS. Dr. Khaku has also served on the Florida Society of Neurology Executive Board
Orhan Altay has 9 years experience in Neurosurgery in Turkey and 2 years translational stroke experience with animals as a Post-doc in molecular neuroscience group near Dr John H Zhang and Dr Tang in Loma Linda University, California. He published 15 articles last 2-3 years in almost high impact journals. He studied with SAH ENDOVASCULAR MONOFILAMENT modal in mice. As a first author among these published articles; 1) CRITICAL CARE MEDICINE (apoptosis) 2) STROKE (blood-brain barrier) 3) NEUROBIOLOGY OF DISEASE (inflammation) 4) HEPARIN + SAH (unpublished but ready to submit without mechanism study). He also has knowledge and experience with applying immunohistochemical and histological techniques, tissue slice, neuroanatomy, using confocal microscopy and protein analysis (Western blots technique).
Treatment for early brain injury after neurovascular injury and pain;
Mechanism of vasospasm generation;
Treatment for intracerebral hemorrhage, demans, epilepsy.
Miguel Pappolla has virtually been the first investigator to identify evidence of oxidative stress in Alzheimer's disease brain. His scientific work includes more than 100 publications and book chapters in neuroscience. His research is cited in several thousand textbooks worldwide. Along with Dr. Larry Refolo, Dr Suzana Petanceska at the National Institutes of Health (NIH) and others, he conducted groundbreaking research on cholesterolemia as an early risk factor for Alzheimer's disease. As a neuropathologist, he described several unique neuropathologic lesions including the colloid body of Parkinson's disease (later renamed "pale body") and the ubiquitinilated "dot like inclusions" in the aged brain. One other area of research is the development of neuroprotective drugs. He produced several patents; one of these drugs is currently on phase 2 clinical trial for Friedriech's ataxia (OX1, a melatonin analog). His training includes medical residencies and fellowships training in Neurology and Pain Medicine (Anesthesia based) and also in Clinical Pathology, Anatomic Pathology, and Neuropathology. This training required 10 additional years of formal medical education (following graduation from Medical School) all pursued in programs accredited by the American Board of Medical Specialties considered the "gold-standard" in physician education in the United States. He holds active board-certifications in 5 disciplines of Medicine (Pain Management, Neurology, Anatomic Pathology, Clinical Pathology and Neuropathology).
He has also been serving the public at large for over 20 years as a consultant for the NIH and a full Professor or Faculty at several of the most prestigious medical schools in the USA (LSU New Orleans, Mount Sinai Medical School in New York City, University of Texas at Houston) where he taught Neurosciences to medical students and medical residents for over 20 years. He has also served as Chairman of Neurology and Director of Neurosciences in one of the largest tertiary care centers in Mississippi, till about the time when his practice was disrupted by hurricane Katrina, when he relocated to Houston, Texas. In addition to participating in several research projects, he also practices pain medicine in Houston, Texas in a private practice setting (www.SMPSclinic.com).
Michelle Conover is a licensed psychologist and Q.M.E., trained at Pacifica, Fielding and UCLA. She specializes in clinical and forensic neuropsychology with particular training and experience with traumatic head injury and neurodegenerative diseases. She has worked with children, adults and geriatric populations as well as specific populations such as professional athletes and criminal offenders. She has treated individuals with TBI, PTSD, Autism, Asperger’s, ADD/ADHD, learning difficulties, stroke, personality disorder, addiction and other complicating diseases such as Alzheimer’s. She is the clinical director and owner of Southern California Neuropsychology Group (www.socalnpg.com) in Woodland Hills, CA where she provides neuropsychological assessment, cognitive rehabilitation and neuro-psychotherapy.
Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.
Psychiatric morbidity in stroke, namely dementia, cognitive impairment, depression, anxiety, apathy, fatigue, emotional incontinence, suicidality, insomnia, pain, and quality of life.
Dr. Sreenivasulu N Pattipati received his Ph.D. in Neuropharmacology from the Panjab University, Chandigarh, India. After his graduation, he worked as an Assistant Professor of Pharmacology at Panjab University. He had postdoctoral training (Cannabinoid Research), at the Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA. After the postdoctoral training, he spent 7 plus years in the Pharmaceutical Industry and involved in several new drug discovery programs. His research interest includes Neuropharmacology, affective and neurodegenerative disorders, pain and inflammation and fibrotic disorders. He has outstanding records of scientific and academic accomplishments with multiple research funding, numerous publications in highly prestigious journals and various presentations at both national and international conferences. He was the recipient of various national and international awards for his outstanding scientific contributions, including “Rafelson Young Investigator Award” by the International College of Neuropsychopharmacology. He served as a scientific reviewer for various journals of national and international repute and for research institutions.
Neuropharmacology; Pain and inflammation (Acute and chronic inflammatory (Rheumatoid arthritis) and neuropathic pain disorders, including diabetic peripheral neuropathy; Role of endocannabinoid system and Development of endocannabinoid based drugs, particularly fatty acid amide hydrolase inhibitors for the treatment of pain and inflammatory disorders); Affective and Neurodegenerative disorders; Fibrotic disorders.
Rodney Leacock has been about 20 years that he have participated in stroke care. In 1991 carotid endarterectomy became the gold standard for symptomatic internal carotid artery disease. Much research has been published on this topic even today. More recently the CREST study has facilitated the incorporation of endovascular therapies when indicated.
When intravenous thrombolysis for acute ischemic stroke was proven beneficial in December 1995 and subsequently FDA approved in 1996, he recall the reluctance to administer for various reasons but mostly because of the concern for hemorrhage. Through efforts of the BAC and the formation of Primary Stroke Centers, Comprehensive Stroke Centers, most recently Acute Stroke Ready Hospitals and the tremendous increase in awareness and benefit there has been a significant increase in acute stroke response and care since 1996. Admittedly stroke remains a leading cause of disability and mortality world- wide. When tPA was first approved, the thrombolysis rates for acute ischemic stroke were less than 1 % in eligible patients and since the formation of Stroke Centers of Excellence we have gone from less than 3% to at or near 10% in about 10 years.
Another transformation is the way we care for aneurysmal subarachnoid hemorrhage in shifting from a predominantly craniotomy clipping approach to an endovascular coiling and stenting treatment. A ruptured intracranial aneurysm still remains a very daunting clinical phenomenon to care for. Again he has participated in the discussions how best to manage aSAH over the years and they have always been enlightening.
There are many foci in the stroke care continuum ranging from stroke recognition and awareness, emergency medical services, treatment, rehabilitation, education, research, and prevention. More emphasis needs to be put on recognition, prevention and research. We have come a long way but there is still a long way to go!
A cross sectional point prevalence study in neurocritical care, Prospective Ischemic Stroke, Acute Ischemic Stroke Quality and Outcomes
Dr. Tolga Tuncer was born in the United States and raised in Ankara, Turkey, he has completed four medical fellowships, the most recent in Hematology and Medical Oncology at the University of Arizona Cancer Center in Tucson, Arizona. Dr. Tuncer completed his Neuro-oncology fellowship at the internationally-renowned Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona.
Dr. Tuncer, a United Council for Neurologic Subspecialties certified Neuro-oncologist, is part of the multidisciplinary Brain and Spine Tumor Program at Saint Luke’s. As the oncologist on the team, he works with the cross-discipline brain tumor committee to offer the most advanced treatments and clinical trials for primary and metastatic brain, spine, and peripheral nervous system tumors.
Prior to his arrival at Saint Luke's, he was the Director of Neuro-Oncology at West Michigan Cancer Center in Kalamazoo, Michigan. He earned his medical degree from the University of Ankara School of Medicine and completed his first residency in Radiation Oncology at the University of Istanbul. He is currently triple-board certified in internal medicine, Neuro-Oncology, and Medical Oncology, and is board-eligible in Hematology. His clinical interests include primary central nervous system tumors, metastatic central nervous system tumors, lung cancer, and cervical cancer. He has transdisciplinary experience and interpersonal skills enable him to communicate effortlessly to various physicians of different backgrounds, a skill essential in the treatment of Neuro-oncology patients.
Brain tumors; Gliomas; Spinal cord tumors; Brain metastases; Central nervous system lymphoma.
Dr. Bonafina earned her psychology degree from the University of Buenos Aires in 1993 and her doctorate in psychology with a specialization in neuropsychology from the City University of New York in 2003.
Dr. Bonafina completed her internship and post-doctoral fellowship at New York University School of Medicine-Bellevue Hospital Center. She worked as a Research Scientist within the Department of Neuroscience at the New York State Psychiatric Institute. She later worked as the Assistant Director of the Traumatic Brain Injury Unit at Bellevue Hospital.Later, She held a position as Senior Psychologist at the 9/11-World Trade Center Health Care Program. She also worked as a neuropsychologist in the Department of Rehabilitation at Cedars-Sinai Medical Center in Los Angeles. Most recently, Associate Director of the International Pogram of the Northeast Regional Epilepsy Group. Since 2010, She is an External Consultant in Neuropsychology and Clinical Psychology in Federal Agencies. She is a highly recognized expert in Forensic Neuropsychology.
In 2003, She was appointed as Clinical Assistant Professor in the Department of Psychiatry at New York University School of Medicine. In 2005, she became Adjunct Assistant Professor at Columbia University. From 1987 until 1995, She worked as a Professor of Neurophysiology and Neuropsychology in the University of Buenos Aires.She has been on the board of several scientific societies and advisory committees. She received various awards.She is frequently invited as keynote speaker in conferences held nationally and internationally.
BarryW. Festoff grew up in South Florida and after graduation from high school he attended the University of Florida at Gainesville. In his sophomore year he decided to take pre‐medicine course with the possibility of attending medical school. He was accepted and attended the University of Miami, now Miller, School of Medicine where he began an interest in research. He furthered this at Duke University Medical School where I did an internship in medicine and was then accepted into the Research Training Program (RTP) in Molecular Biology, an NIH‐funded program for interns and medical students. Following a neurology residency back at the University of Miami‐‐Jackson Memorial Hospital, he spent 5 years in the Medical Neurology Branch of the NINDS at the NIH in Bethesda, MD where he spent my military requirement.In1976 he was recruited to the University of Kansas and Kansas City VA Medical Centers where he established neuroscience research and built a clinical neurology program. He retired from the VA in 2010 and founded pHLOGISTIX, a neurodiagnostic and therapeutic biotech company. His career has been involved with translational research into neurologic diseases, especially the relationship with neurotrauma as antecedent. They are focusing on blood‐based biomarkers as companion diagnostics for neurotrauma and neurodegenerative diseases such as chronic traumatic encephalopathy (CTE), Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) in order to harness neuroinflammation and improve functional outcomes following CNS trauma. As a part of this biomarkers project they will utilize mouse AD transgenic models with or without controlled cortical impact (CCI)/traumatic brain injury (TBI) taking both plasma DNA and plasma proteomics approaches. They emphasize mitochondrial DNA (mtDNA) and protein biomarkers and will compare mouse samples with the well‐characterized plasma proteome ADNI dataset in this proposal. The ultimate goal of the proposed research is to provide a validated panel of nucleic acid and protein biomarkers in a novel analytic approach to allow identification of preclinical CTE and AD while stillat the stageof mild cognitive impairment (MCI) or following mild TBI permitting us toinitiate treatment before permanent sequelae result. Their goal is to obtain a validated combinatorial panel of plasma biomarkers using a novel in vitro approach todiagnose and monitor CTE andAD prognosis after TBI, and to reveal novel therapeutic targets in these conditions.
Moleculare Targeted Therapy and Virotherapy in Neuro-Oncology in Humans and Animal Models;;
Blood Brain Barrier;
Biomarkers In Neurology and Neurosurgery
Dr. Nazer H Qureshi, M.D, D.Stat, M.Sc, DABNS, FAANS, graduated from Medical School with top honors and first position in Anatomy and Histology in board examinations. Pursued surgical training in Europe, including neurosurgery at the National Center for Neurosurgery affiliated with The Royal College of Surgeons of Ireland. In 1994 started as a junior faculty member at the University of Dublin teaching medical students while pursuing his own research on “Interleukin-1 binding and expression in brain” towards a Masters in Science. During that year also attained a Diploma in Statistics from University of Dublin. In summer of 1995 was a visiting fellow at the University of Toronto working on use-dependent inhibitory depression in epilepsy models. In 1996 migrated to US and completed a research fellowship in gene therapy for brain tumors at Harvard Medical School/Massachusetts General Hospital. The work on gene therapy that included testing efficacy and toxicity of different viral vectors and & designing a novel method of gene delivery to human brain tumors culminated into a clinical trial. In 1999 completed a neurosurgery fellowship at the University of Arizona. Completed 2 years of accredited General Surgery residency at Tuft’s University and Thomas Jefferson University, followed by Neurosurgery Residency in June 2008 from the University of Arkansas for Medical Sciences with “Prof. Iftikhar A. Raja Humanity in Medicine Award.” Diplomate, American Board of Neurological Surgeons and Fellow of the American Board of Neurological Surgeons. Worked as an attending neurosurgeon at the Baptist Hospital Medical Center in Little Rock the chief of brain and spine tumor service at Baptist Health Medical Center, North Little Rock.
Recipient of University merit scholarship and Quaid-e-Azam Aligarh scholarship in medical school and recipient of education and training grant from North-West health board in Ireland. Listed in Who’s Who of International Professionals (1999). Held symposium chair for “Advances in Gene Therapy for Neurological Disorders” at the Internet Association for Biomedical Sciences 2000 Meeting. Written seven book chapters and more than 35 papers, abstracts and oral presentations at conferences in US, Europe and Far East. Authored neuroscience/neurosurgery and neuroanatomy teaching material published on CD-ROM and palmpilots. From 2004-2008 was a reviewer for “Practical Reviews in Neurosurgery”- an audio and written journal published by Oakstone Medical Publishing in association with AANS. Served as a resident delegate in the Council of State Neurosurgical Societies (CSNS) for the year 2006-2007; and, served on two of the subcommittees to help and write questions for SANS wired.
Neurodegeneration and Neuroregeneration studies, using cell and tissue culture models as well as animal and human models of neurodegenerative disorders and diseases using cell and molecular biology methods
Histochemical and immunochemical methods, drug-induced changes in neurodegenerative disorders and changes in their signaling activities.
Humberto Mendes Faria Rodriguesmade the Bachelor and Master in Clinical and Health Psychology at the University of Aveiro (Portugal). In the meantime, he performed a research project in the field of Biofeedback / Neurofeedback by the Foundation for Science and Technology(FCT). He trained Psychology in the Centre of University Hospital at Coimbra (e.g.,Intervention in Sleep Disorders and Pain Disorders. Later he worked as a psychologist and neuropsychologist in the office of Neuropsychology Luís Maia PhD. Currently he is working with the Institution of Solidarity Projecto Homem / Braga in the area of additions and parallel he do outpatient consultations in various psychological disorders with the collaboration of a psychiatrist.Concomitantly he made several national and international communications in divers Congress as Guest Speaker in the field of Neuroscience. Author of several articles in peer review journals. Co-founder and Editor Associate of theIberian Journal of Clinical and Forensic Neuroscience (2013-2014).At the moment he is PhD student in Neuroscience at the Faculty of Medicine, University of Salamanca - Neurosciences Institute of Castilla y León.
Assessment and Neuropsychological Rehabilitation, Drug Abuse and Addiction, Behavioural Neuroscience, Behavioural Management, Biofeedback/Neurofeedback, Sleep Disorders, Pain Disorders, Mindfulness.
Magnus Gram is a researcher at the Department of Pediatrics, Division of Clinical Sciences, Lund University, Sweden. After obtaining his PhD from Department of Infection Medicine and training in Cell & Molecular Biology, Redox Biology and Extracellular Hemoglobin Toxicity, he moved in to the field of Neurobiology and the group of Professor David Ley, with particular focuses on the neuroprotection of newborn brain. He has published more than 25 peer reviewed articles, is a co-author of 5 patent applications, is a guest associate editor for Frontiers in Oxidant Physiology and serves as a regular reviewer for several journals in the field of Cell & Molecular Biology, Redox Biology and Biochemistry. His recent work has focused on mechanisms of brain injury following intraventricular hemorrhage in preterm infants and the development of new therapies.